Comparison of standard carbidopa–levodopa and sustained‐release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality‐of‐life measures (Q53590333)
scientific article published on September 1, 1997
Language:
(P31) (Q13442814)
(P50) (Q67208105)
(Q67211247)
(Q64857746)
(Q67241573)
(P304) 677-681
(P407) (Q1860)
(P433) 5
(P478) 12
(P577) Monday, September 1, 1997
Monday, September 1, 1997
(P921) (Q13100823)
(Q300989)
(Q11085)
(Q5037862)
(Q323936)
(P953) https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.870120508
https://onlinelibrary.wiley.com/doi/full/10.1002/mds.870120508
(P1433) (Q1486418)
(P1476) "Comparison of standard carbidopa–levodopa and sustained‐release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality‐of‐life measures" (language: en)
"Comparison of standard carbidopa-levodopa and sustained-release carbidopa-levodopa in Parkinson's disease: pharmacokinetic and quality-of-life measures" (language: en)
(P2093) P. Silverstein
F. Zwiebel
M. Robischon
(P2860) (Q28329780)
(Q44040415)
(Q48872325)
(Q42219649)
(Q43829541)
(Q70795079)
(Q46654208)
(Q68003968)
(Q44249650)
(Q55063071)
(Q48163316)
(Q70289020)
(Q33630164)
(Q69388415)
(Q46654208)
other details
description scientific article published on September 1, 1997

External Links